To view this email as a web page, click here.
 
Drugstore retailers pull Zantac as recalls expand
Pharmacy chains pull ranitidine and Zantac products off the shelves over cancer concerns.
Read more
 
FDA expands Mavyret for certain hepatitis C patients
Drug is first 8-week treatment approved for this type of HCV.
Read more
 
FDA issues warning for certain hepatitis C drugs
Use of these meds to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in liver failure in rare cases.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.